Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Depreciation & Amortization (CF) (2024 - 2025)

Carlsmed's Depreciation & Amortization (CF) history spans 2 years, with the latest figure at $98000.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 164.86% year-over-year to $98000.0; the TTM value through Dec 2025 reached $317000.0, changed N/A, while the annual FY2025 figure was $281000.0, 93.79% up from the prior year.
  • Depreciation & Amortization (CF) reached $98000.0 in Q4 2025 per CARL's latest filing, up from $82000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $100000.0 in Q2 2024 to a low of $33000.0 in Q3 2024.